SCRI - Florida Cancer Specialists - West Palm Beach — West Palm Beach, Florida

SCRI - Florida Cancer Specialists - West Palm Beach is a clinical research site located in West Palm Beach, Florida, United States 33401.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI - Florida Cancer Specialists - West Palm Beach has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Triple Negative Breast Cancer, PD-L1 Positive.

Sponsors: Genmab, Gilead Sciences, Mirati Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in West Palm Beach

Browse all research sites in Florida · View every site in West Palm Beach

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Florida Cancer Specialists - West Palm Beach?

SCRI - Florida Cancer Specialists - West Palm Beach has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Florida Cancer Specialists - West Palm Beach conducted?

SCRI - Florida Cancer Specialists - West Palm Beach has 4 clinical trials on record, with 3 currently active. Their work covers Platinum-resistant Ovarian Cancer, Triple Negative Breast Cancer, PD-L1 Positive.

Is SCRI - Florida Cancer Specialists - West Palm Beach accredited by Crixeo Clinical Trials?

SCRI - Florida Cancer Specialists - West Palm Beach has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Florida Cancer Specialists - West Palm Beach?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.